Kimmet Pamela O 4

What Happened

• Pamela O. Kimmet, a director of Privia Health Group, received a grant of 8,463 restricted stock units (RSUs) on May 20, 2026. The Form 4 reports an acquisition price of $0.00 for the award, which is standard for RSU grants (no cash paid by the insider). This is an equity compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: May 20, 2026. Form 4 filed: May 22, 2026 (appears timely — within the typical two-business-day window).
• Transaction code: A (award/grant). Shares acquired: 8,463 RSUs; reported acquisition price: $0.00.
• Vesting: RSUs vest on the earlier of (i) the day immediately preceding the Company’s 2027 annual meeting of stockholders, or (ii) the first anniversary of the grant (May 20, 2027), per the filing footnote.
• Shares owned after the transaction: Not specified in the provided Form 4 excerpt.
• No 10b5-1 plan, cashless exercise, gift, or tax-withholding note indicated in the provided details.

Context

• RSU grants are common director compensation and represent a future right to receive shares if vesting conditions are met; they are not an immediate market purchase or sale. The ultimate value to the insider depends on Privia’s stock price at vesting and any company-forfeiture provisions. This filing documents routine equity compensation rather than an explicit bullish or bearish trading signal.